Effect of asymmetric dimethylarginine (ADMA) on heart failure development

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases that limits nitric oxide bioavailability and can increase production of NOS derived reactive oxidative species. Increased plasma ADMA is a one of the strongest predictors of mortality in patients who have had a m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nitric Oxide
Auteurs principaux: Liu, Xiaoyu, Hou, Lei, Xu, Dachun, Chen, Angela, Yang, Liuqing, Zhuang, Yan, Xu, Yawei, Fassett, John, Chen, Yingjie
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5017793/
https://ncbi.nlm.nih.gov/pubmed/26923818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.niox.2016.02.006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires